CHANIN HILAND: Open Payments
NPI 1376800250 · EDDYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 21 payments from 13 companies in 2025. Trend: 2023 $469 · 2024 $293 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: LEQVIO, Wegovy, REXULTI, VOQUEZNA, WATCHMAN Access System, MOUNJARO, Auvelity, CAPLYTA.
Industry payments across KY — which companies pay providers there.
